Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Total Current Liabilities: 2015-2024

Historic Total Current Liabilities for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $77.2 million.

  • Editas Medicine's Total Current Liabilities fell 14.62% to $61.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year decrease of 14.62%. This contributed to the annual value of $77.2 million for FY2024, which is 22.16% up from last year.
  • Per Editas Medicine's latest filing, its Total Current Liabilities stood at $77.2 million for FY2024, which was up 22.16% from $63.2 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Total Current Liabilities ranged from a high of $77.2 million in FY2024 and a low of $46.9 million during FY2021.
  • Over the past 3 years, Editas Medicine's median Total Current Liabilities value was $63.2 million (recorded in 2023), while the average stood at $66.9 million.
  • Per our database at Business Quant, Editas Medicine's Total Current Liabilities fell by 19.45% in 2021 and then rose by 28.21% in 2022.
  • Yearly analysis of 5 years shows Editas Medicine's Total Current Liabilities stood at $58.2 million in 2020, then decreased by 19.45% to $46.9 million in 2021, then grew by 28.21% to $60.1 million in 2022, then grew by 5.17% to $63.2 million in 2023, then rose by 22.16% to $77.2 million in 2024.